2016 annual financial data
GT Biopharma 2016 Operating margin
GT Biopharma 2016 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -9,374,000 USD and net income was 9,768,000 USD.
Operating cash flow was -1,930,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,374,000 USD
- Net income
- 9,768,000 USD
- Operating cash flow
- -1,930,000 USD